Sign up today and learn more about Synthorx Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Synthorx Stock
Synthorx is a biotechnology company using ground-breaking synthetic biology starting with our novel DNA base pair to discover and develop new protein therapeutics. The company uses new building blocks to create proteins that impart specificity not possible with native proteins. The result is treatments with improved efficacy, better safety, and better convenience for patients. Utilizing proprietary engineered organisms we have the ability to manufacture these improved proteins with high fidelity and the required yield for drug discovery and development. This unique platform expands the chemical and structural repertoire of protein therapeutics and uncovers new ways to modulate pharmacological properties of biologics, not possible with other technologies.
Getaround, mParticle, Casper, Earnest, Personal Capital, Imperfect Foods, BlueVine, Alloy, Optimizely, Good Eggs
Chief Scientific Officer
President and CEO
Founder and Director
Floyd E. Romesberg
Wall Streets Journal - Dec, 9 2019Sanofi Chief Signals Focus on Cancer With $2.5 Billion Deal
Herald Keeper - Jun, 12 2018Synthetic Biology Market is Determined to Cross US$ 38 Billion By 2020
Reuters - Apr, 30 2018BRIEF-Synthorx Completes $63 Mln Series C Financing Led By OrbiMed
- Apr, 30 2018Synthorx Announces $63 Million Series C Financing to Advance a Pipeline of Synthorin™ Cytokines
Endpoints News - Dec, 1 2017Laura Shawver hits the ground running, scouting new investors for tiny Synthorx
PR Newswire (press release) - Nov, 29 2017Scientists at TSRI and Synthorx Create the First Semi-Synthetic Organism to Encode and Translate Expanded Genetic ...
PR Newswire (press release) - Nov, 27 2017Laura Shawver, Ph.D., Appointed CEO of Synthorx
PR Newswire (press release) - Aug, 14 2017Synthorx Appoints Marcos Milla, Ph.D. as Senior Vice President of Research
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase